Robert Quirke, CEO and President of ROQU Group, pictured at the pilot launch.

Health Passport Ireland – a world-first digital platform designed to facilitate increased Covid-19 testing for businesses and the public – is being rolled out on a trial basis across a range of hospitals, nursing homes, businesses and community centres.

Engineered in Ireland, the platform by Irish-based ROQU Group combines the latest digital technologies with accurate and validated Covid-19 testing solutions, which can deliver results in as little as 15 minutes.

The digital platform is a big step towards helping businesses and individuals to quickly minimise risks related to Covid-19 and ensure they can continue daily activities. The system has been designed to work will all official Covid-19 test types.

The pilot trial will involve a select range of national participants including Tallaght University Hospital and Oaklodge Nursing Home. “Health Passport Ireland is designed to put a safety net in place where none currently exists, allowing our economy to recover and thrive in a more safely controlled environment. The game changer has finally arrived,” noted Robert Quirke, President and CEO of ROQU Group, at the pilot launch.

Health Passport Ireland has been developed specifically to work with all official Covid-19 tests, including HSE tests, laboratory swab and blood tests, and the very latest rapid testing solutions soon to be launched.

“We’re not favouring one type of test over another. However, as testing and research improves, we want to ensure that Irish society and economy can easily access testing solutions that offer the highest levels of clinical validation, whilst utilising latest mobile technologies,” according to Quirke.

In addition to Ireland, the Health Passport platform will also be launched in the US, UK, Italy, Kenya and Germany, with other locations to follow.